XML 73 R59.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Narrative) (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Nov. 22, 2021
shares
Sep. 20, 2021
USD ($)
item
$ / shares
shares
Apr. 21, 2021
shares
Nov. 30, 2020
USD ($)
$ / shares
shares
Aug. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
item
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
Dec. 31, 2018
USD ($)
shares
Dec. 02, 2020
shares
Aug. 04, 2020
shares
Oct. 31, 2010
$ / shares
Stockholders' Equity [Line Items]                        
Common stock, dividends declared | $ / shares           $ 0            
Voting right of common stock share holders           one            
Voting right of common stock share holders, number of votes | item           1            
Proceeds from issuance of common stock from underwritten public equity offerings, net of issuance costs | $           $ 294,845 $ 187,479          
Stock-based compensation cost capitalized in inventory | $           $ 900 $ 300          
Common Stock Shares Issued           220,978,000 192,294,000          
Proceeds From Issuance Of Common Stock | $           $ 31,806 $ 46,360 $ 8,548        
Weighted average grant date fair value per share | $ / shares           $ 18.36 $ 4.14          
Common Stock Par Or Stated Value Per Share | $ / shares           $ 0.001 $ 0.001         $ 0.001
Private Placement of Common Stock [Member]                        
Stockholders' Equity [Line Items]                        
Price per share | $ / shares   $ 26.75                    
Common Stock Shares Issued   11,214,953                    
Proceeds From Issuance Of Common Stock | $   $ 300,000                    
Common Stock [Member]                        
Stockholders' Equity [Line Items]                        
Shares issued             29,356,000          
Weighted average remaining contractual life           5 years 1 month 13 days            
Omniome Plan [Member]                        
Stockholders' Equity [Line Items]                        
Exchange ratio | item   0.259204639                    
Shares authorized   2,494,128                    
2010 Plan [Member]                        
Stockholders' Equity [Line Items]                        
Common stock remain available for issuance           21,500,000            
ESPP [Member]                        
Stockholders' Equity [Line Items]                        
Common stock remain available for issuance           7,810,673            
Percentage of outstanding common stock used to determine annual plan increase           2.00%            
Number of purchase periods | item           4            
Purchase period of ESPP           6 months            
Percentage of fair market value at which stock can be purchased           85.00%            
Common stock purchased under plan           1,913,968 834,677   1,306,329      
Cash received from option exercises | $           $ 6,400 $ 2,400   $ 2,700      
Common Stock Shares Issued           4,000,000            
2020 Equity Incentive Plan [Member]                        
Stockholders' Equity [Line Items]                        
Shares authorized                     11,000,000  
2020 Inducement Equity Incentive Plan [Member]                        
Stockholders' Equity [Line Items]                        
Shares authorized                   2,500,000    
Additional common stock reserved for issuance 360,000   750,000                  
Common stock remain available for issuance           8,100,000            
Underwritten Public Equity Offering [Member]                        
Stockholders' Equity [Line Items]                        
Shares issued           29,400,000            
Proceeds from issuance of common stock from underwritten public equity offerings, net of issuance costs | $           $ 187,200            
Number of offerings | item           2            
Price per share | $ / shares           $ 6.40            
Underwriting Agreement [Member]                        
Stockholders' Equity [Line Items]                        
Public offering       6,096,112 19,430,000              
Common stock offering price per share | $ / shares       $ 14.25 $ 4.47              
Public offering, option to purchase additional shares, period       30 days 30 days              
Public offering, option to purchase additional shares, shares       914,416 2,914,500              
Shares issued       7,000,000.0 22,300,000              
Commissions, percentage of gross proceeds       6.00% 6.00%              
Proceeds from issuance of common stock from underwritten public equity offerings, net of issuance costs | $       $ 93,900 $ 93,900              
Offering costs | $       $ 300 $ 300              
Common Stock Par Or Stated Value Per Share | $ / shares       $ 0.001 $ 0.001              
Options to purchase common stock [Member]                        
Stockholders' Equity [Line Items]                        
Options expired           20,000.00            
Aggregate intrinsic value outstanding | $           $ 147,900            
Aggregate intrinsic value exercisable options | $           $ 121,400            
Stock price | $ / shares             $ 20.46          
Vested and expected to vest, outstanding           11,535,217            
Vested and expected to vest, aggregate intrinsic value | $           $ 141,900            
Vested and expected to vest, weighted average exercise price | $ / shares           $ 10.46            
Vested and expected to vest, weighted average remaining contractual life           6 years 3 months 10 days            
Total intrinsic value of options exercised | $           $ 146,100 $ 63,100   2,600      
Unrecognized compensation costs | $           122,900            
Cash received from option exercises | $           $ 25,400 $ 43,900   $ 5,900      
Weighted average grant date fair value per share | $ / shares           $ 15.53 $ 7.20        
Options to purchase common stock [Member] | Common Stock [Member]                        
Stockholders' Equity [Line Items]                        
Weighted average remaining contractual life           2 years 10 months 24 days            
Options to purchase common stock [Member] | $1.16 – 20.90 [Member]                        
Stockholders' Equity [Line Items]                        
Options expired, weighted average exercise price | $ / shares           $ 9.80            
RSUs with time-based vesting [Member]                        
Stockholders' Equity [Line Items]                        
Ratio of number of shares into which the share instrument may be converted           1            
Vesting period           4 years            
Share-based Compensation Award, Tranche One, Two, Three and Four [Member] | RSUs with time-based vesting [Member]                        
Stockholders' Equity [Line Items]                        
Vesting percentage           25.00%